In vitro and in vivo assays of protein kinase CK2 activity

Methods in Enzymology

Volumn 485, Issue C, 2010, Pages 597-610

  Prudent, Renaud ^a   Sautel, Céline F ^a   Moucadel, Virginie ^a   Laudet, Béatrice ^a   Filhol, Odile ^a   Cochet, Claude ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; ENZYME INHIBITOR; LENTIVIRUS VECTOR; MBP CK2BETA; REAGENT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

BINDING ASSAY; BIOTINYLATION; BOOK; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SUBUNIT; FLUORESCENCE ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE AMPLIFICATION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; WESTERN BLOTTING;

EID: 78049500726     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381296-4.00031-2     Document Type: Chapter

References (18)

1. Chantalat L., et al. Crystallization and preliminary X-ray diffraction analysis of the regulatory subunit of human protein kinase CK2. Acta Crystallogr. D Biol. Crystallogr. 1999, 55:895-897.
2. Duncan J.S., Litchfield D.W. Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim. Biophys. Acta 2008, 1784:33-47.
3. Filhol O., Cochet C. Cellular functions of protein kinase CK2: A dynamic affair. Cell. Mol. Life Sci. 2009, 66:1830-1839.
4. Filhol O., et al. Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits. Mol. Cell. Biol. 2003, 23:975-987.
5. Filhol O., et al. Protein kinase CK2: A new view of an old molecular complex. EMBO Rep. 2004, 5:351-355.
6. Heriche J.K., et al. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. Science 1997, 276:952-955.
7. Kerppola T.K. Bimolecular fluorescence complementation: visualization of molecular interactions in living cells. Methods Cell. Biol. 2008, 85:431-470.
8. Laramas M., et al. Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer. Eur. J. Cancer 2007, 43:928-934.
9. Laudet B., et al. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction. Biochem. J. 2007, 408:363-373.
10. Leroy D., et al. Mutations in the C-terminal domain of topoisomerase II affect meiotic function and interaction with the casein kinase 2 beta subunit. Mol. Cell. Biochem. 1999, 191:85-95.
11. Litchfield D.W. Protein kinase CK2: Structure, regulation and role in cellular decisions of life and death. Biochem. J. 2003, 369:1-15.
12. Mangeot P.E., et al. High levels of transduction of human dendritic cells with optimized SIV vectors. Mol. Ther. 2002, 5:283-290.
13. Martel V., et al. p53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2. Oncogene 2006, 25:7343-7353.
14. Niefind K., et al. Crystal structure of human protein kinase CK2: Insights into basic properties of the CK2 holoenzyme. EMBO J. 2001, 20:5320-5331.
15. Pinna L.A. Protein kinase CK2: A challenge to canons. J. Cell Sci. 2002, 115:3873-3878.
16. Prudent R., et al. Salicylaldehyde derivatives as new protein kinase CK2 inhibitors. Biochim. Biophys. Acta 2001, 1780(12):1412-1420.
17. Ruzzene M., Pinna L.A. Addiction to protein kinase CK2: A common denominator of diverse cancer cells?. Biochim. Biophys. Acta 2009, 1804(3):499-504.
18. Zhang J.H., et al. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4:67-73.